SWIFT: ulcerative colitis clinical research study

Clinicaltrials.gov ID: NCT06290934

IF YOU HAVE ULCERATIVE COLITIS AND CONTINUE TO EXPERIENCE SYMPTOMS, THE SWIFT CLINICAL RESEARCH STUDY MAY BE FOR YOU.

• Are you currently experiencing symptoms such as diarrhoea with or without blood, stool urgency, or incontinence of stool, and;

• Have been diagnosed with Ulcerative Colitis (UC), and;

• Be 18-75 years, and;

• Meet eligibility criteria during screening at a participating site.

This is a randomised, double-blinded, placebo-controlled study with an oral investigational drug to see if it reduces the sign and symptoms of moderately to severely active UC.

This study also evaluates if there are any adverse events or other safety issues associated with the investigational drug.

The investigational drug is taken as 3 tablets once a day.

• You may be in the study for at least 12 weeks or up to 76 weeks depending how you respond to the investigational drug or placebo.

• After the first 12 weeks, all participants allocated to placebo group will have the opportunity to receive the investigational drug until the conclusion of the study.

You don’t need health insurance or referral to participate.

 It will not cost you anything to participate in the study. The oral investigational medications will be provided at no charge to you, and you will not be charged for any visits or procedures performed for this study

Find study locations near you for more information

State	Site	Contact
NSW	Macquarie University Hospital	Macquarie Clinical Trials Unit 02 9812 2956 [email protected]
QLD	Princess Alexandra Hospital	Teressa Hansen 07 3176 2133 [email protected]
VIC	Northern Health	Gastroenterology research coordinator 03 8405 2290 [email protected]
VIC	Western Health	Kerrie Curin 03 8345 6291 [email protected]
VIC	St Vincent Hospital, Melbourne	Isobel Brewster 03 9231 3566 [email protected]
QLD	Mater Adult Hospital	Sharyn Grossman 07 3163 8195 [email protected]

NOTE: Further sites will be added at a later date